News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AnaSpec, Inc. Introduces MOG (35-55), Mouse, Rat Peptide



8/29/2011 10:11:43 AM

Fremont CA – Aug 29, 2011 -- AnaSpec is pleased to support advances in MS research by providing MOG (35 - 55), mouse, rat, a key peptide that induces severe chronic experimental autoimmune encephalomyelitis in transgenic mice. AnaSpec’s MOG (35-55) peptide from mouse and rat sequence (cat# 60130) has been shown to induce anti-MOG (35-55) autoantibody production in C57BL/6 mice at 100% incidence (10/10), indicating that this peptide is the clear choice for in vivo anti-MOG (35-55) autoantibody study.

In addition to this peptide, AnaSpec also provides a large selection of MOG peptides of varied sequences and lengths, and MBP (myelin basic protein) and PLP (proteolipid proteins) peptides, two other potential primary encephalitogenic target antigens in multiple sclerosis.

To obtain a price quote for larger quantity of the MOG (35-55) peptide, please email service@anaspec.com.

For more information, please visit https://www.anaspec.com/products/promotions.asp?col=2&row=2

AnaSpec, EGT Group

AnaSpec, EGT Group is a leading provider of integrated proteomics and genomics solutionsTM for worldwide life science research. AnaSpec offers expertise in peptides, detection reagents, antibodies, assay kits, amino acids, oligonucleotides, and qPCRs. AnaSpec carries a broad product line of biochemicals and reagents for basic research, high-throughput screening and drug discovery. AnaSpec also provides premier custom services including peptide synthesis, antibody production, assay development, fluorescent dyes, and oligonucleotide synthesis. AnaSpec is certified to ISO 9001:2008.

For more information visit www.anaspec.com


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES